A major win in the fight against HIV infections. The Food and Drug Administration approved a new twice-a-year shot to prevent ...

Agricultural researchers discovered how to essentially disarm Fusarium Head Blight, which causes over $1 billion in annual ...

The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.

New cases of HIV-AIDS infections in the country are on the rise, mainly among the youths, with efforts to reduce the numbers ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions – ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...

Depending on what time it is, your body responds differently to an injury or infection. During the day, you're likely to heal faster and fight infection better than at night. Historically ...

Depending on what time it is, your body responds differently to an injury or infection. During the day, you're likely to heal faster and fight... Why you fight infection better in the daytime ...

Since the discovery of penicillin nearly a century ago, antimicrobial resistance (AMR) has become a stealthy, pervasive enemy in the fight against bacterial infections. AMR claims an estimated 1. ...

The findings could encourage additional research into the potential therapeutic uses of SSRIs during infection. “When treating an infection, the optimal treatment strategy would be one that ...